[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @GeneInvesting Gene Investing w/Anthony 🧬 Gene Investing w/Anthony 🧬 posts on X about $ntla, $crsp, $prme, $beam the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours. ### Engagements: XXXXXX [#](/creator/twitter::1246632233579896833/interactions)  - X Week XXXXXX +104% - X Month XXXXXXX -XX% - X Months XXXXXXXXX -XXXX% - X Year XXXXXXXXX -XXXX% ### Mentions: XX [#](/creator/twitter::1246632233579896833/posts_active)  - X Week XX +6.50% - X Month XXX -XX% - X Months XXXXX -XX% - X Year XXXXX +32% ### Followers: XXXXXX [#](/creator/twitter::1246632233579896833/followers)  - X Week XXXXXX +0.75% - X Month XXXXXX +2.20% - X Months XXXXXX +19% - X Year XXXXXX +34% ### CreatorRank: XXXXXXX [#](/creator/twitter::1246632233579896833/influencer_rank)  ### Social Influence [#](/creator/twitter::1246632233579896833/influence) --- **Social category influence** [finance](/list/finance) XXXXX% [cryptocurrencies](/list/cryptocurrencies) #3332 [stocks](/list/stocks) XXXX% [technology brands](/list/technology-brands) XXXX% [countries](/list/countries) XXXX% **Social topic influence** [$ntla](/topic/$ntla) #1, [$crsp](/topic/$crsp) #1, [$prme](/topic/$prme) #1, [$beam](/topic/$beam) #2, [hae](/topic/hae) #26, [insider](/topic/insider) 2.88%, [vivo](/topic/vivo) 2.88%, [money](/topic/money) 2.88%, [$srpt](/topic/$srpt) 1.92%, [$bbio](/topic/$bbio) XXXX% **Top accounts mentioned or mentioned by** [@crisprspace](/creator/undefined) [@rnaianalyst](/creator/undefined) [@jawnzilla](/creator/undefined) [@techstonx](/creator/undefined) [@hassanaesthetic](/creator/undefined) [@carey72290517](/creator/undefined) [@yaireinhorn](/creator/undefined) [@masterlongevity](/creator/undefined) [@robdubparker](/creator/undefined) [@jessiechimni](/creator/undefined) [@steve2bacon](/creator/undefined) [@freshjiva](/creator/undefined) [@lovebostrom](/creator/undefined) [@biotech2k1](/creator/undefined) [@anthonystaj](/creator/undefined) [@rolandoamoreno](/creator/undefined) [@crisprglenn](/creator/undefined) [@bk7959925597715](/creator/undefined) [@vega_n1](/creator/undefined) [@sguiderna](/creator/undefined) **Top assets mentioned** [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [CRISPR Therapeutics AG (CRSP)](/topic/$crsp) [BEAM (BEAM)](/topic/$beam) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Pfizer, Inc. (PFE)](/topic/$pfe) [Muhdo Hub (DNA)](/topic/$dna) [GammaSwap (GS)](/topic/$gs) [Goldman Sachs (GS)](/topic/goldman-sachs) [Eli Lilly and Company (LLY)](/topic/$lly) [Bitcoin Incognito (XBI)](/topic/$xbi) [Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [TG Therapeutics, Inc. (TGTX)](/topic/$tgtx) [Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)](/topic/$mdgl) [Regeneron Pharmaceuticals Inc (REGN)](/topic/$regn) ### Top Social Posts [#](/creator/twitter::1246632233579896833/posts) --- Top posts by engagements in the last XX hours "What a strong close for $NTLA 💪💪💪 +6.81% Also notable: $DNA +17.93% $CRBU +14.49% $ARKG +3.06% $BEAM +2.43% $CRSP and $PRME needed a breather after big runs"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1947749616377598048) 2025-07-22 20:04:30 UTC 13.6K followers, 4073 engagements "@john_hersc79276 Because AAV based gene therapy and LNP based CRISPR are two very different animals"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1948419398517088679) 2025-07-24 16:25:59 UTC 13.6K followers, XXX engagements "I really want to bet someone that this guy is short some biotechs No bull could ever be this consistently negative EVERY SINGLE WEEK 🤦🏻♂ Look at his page a dozen or more $SRPT posts today and I dont see one mention of the $XX million insider buy at $CRSP 👀"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1946290683318251990) 2025-07-18 19:27:13 UTC 13.6K followers, 5903 engagements "Likely the biggest asshole on here. When $PRME was struggling I was comforting him and convincing him to believe in it. He apologized to me for being an asshole a few months ago because he was annoyed at how horrible $PRME and $NTLA were doing. Now he cant stomach X bad days in PRME without reverting to a giant asshole. You try to forgive people but they show their true colors when things go badly for them. Very odd hes not in a better mood considering how well Prime has done recently. Sorry that Prime was only my second favorite stock in the entire market. Ill try to do better next time 😂"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1945503636810833923) 2025-07-16 15:19:47 UTC 13.6K followers, 10.8K engagements "How can anyone trust Goldman Sachs X months ago they downgraded $NTLA from NEUTRAL to SELL with PT of $X. Now with the stock at $XX they put a SPOTLIGHT on only X stocks and Intellia is one of them. I havent seen them adjust their PT but really funny if they have a SELL rating with $X PT and pick it as their top X stocks at $XX. 🤣 Goldman identified three stocks that align with its broader market thesis and are poised to outperform in the second half of 2025: Kohls Intellia Therapeutics and Gogo Inc"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1946315312909242860) 2025-07-18 21:05:06 UTC 13.6K followers, 4248 engagements "$PRME $NTLA $BEAM $CRSP I begged for this for the last 1-2 years and they delivered. Itll be sparingly used at first but my hope is that it can help speed up follow up programs. Ex) HAE helping ATTR PN or PN helping CM. Definitely a slam dunk for CGD if government also reinstates rare disease voucher to help program make economic sense"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1947712960048308389) 2025-07-22 17:38:51 UTC 13.6K followers, 4352 engagements "@mathcoredad But my point is he uses it to try to be negative about all companies lol And he never reports the positive like $CRSP +18% on $XX million insider buy"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1946559693788213480) 2025-07-19 13:16:10 UTC 13.6K followers, XXX engagements "@RNAiAnalyst Ill take it. But I need to read up on this person"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1947285411891470592) 2025-07-21 13:19:55 UTC 13.6K followers, XXX engagements "Going to be fascinating to see what happens with $PRME the next X years. Very surprised no in vivo deals yet. Need rare disease voucher and/or partner for CGD. And will be very interesting what final arbitration result will be with $BEAM regarding AATD. Really bad job by the companies that their initial wording left the need for arbitration. This shouldve been written clearly in the forming documents of Prime"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1945944059580755984) 2025-07-17 20:29:52 UTC 13.6K followers, 4114 engagements "@RNAiAnalyst All time favorite Adam F moment was on $NTLA liver tox he posted about it literally a minute or two after filing and said oh is this new Like he didnt know 😂 And he never reports on the good news because that doesnt sell subscriptions I guess"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1946581562499145815) 2025-07-19 14:43:04 UTC 13.6K followers, 2058 engagements "This is proof as to why every biotech should have at least one person who is a billionaire or mega wealthy 😂 $CRSP The board members must love this guy"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1946205280968065411) 2025-07-18 13:47:52 UTC 13.6K followers, 6743 engagements "$BBIO has turned European Attruby rights into $XXX million in upfront cash (if we count near term $75m). Remarkable considering generic Tafamidis will cause significant pricing pressure within the next few years. Generic taf is a huge reason that $NTLA combo therapy results are SO important. If Intellia shows significant combo benefits itll make a strong case for combo therapy and put less pricing pressure on Intellia. Also Vutrisiran kept price its same for CM (and PN) which helps Intellia. Ive calculated my expectations for Intellias combo therapy and I think it could be significant. Many"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1940105608675426535) 2025-07-01 17:49:57 UTC 13.6K followers, 4739 engagements "Biggest Pros/Cons for the X Leading Gene Editing Companies $CRSP Pros: huge cash pile and pipeline Cons: slow Casgevy (40% ownership) ramp could weigh on stock a lot riding on ex vivo programs which are notoriously lower PoS $BEAM Pros: base editing king solid cash SCD (100%) franchise and AATD (100%) Cons: arbitration with PRME over AATD SCD is a slow commercial process $NTLA Pros: HAE (100%) and ATTR PN/CM (75%) Cons: no pipeline outside of three Ph. X trials needs more cash $PRME Pros: Prime editing king great tech Cons: very little cash so expect significant dilution. Outside of currently"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1943678556061495685) 2025-07-11 14:27:34 UTC 13.6K followers, 9641 engagements "I like how $NTLA is holding up today compared to $CRSP $BEAM and $PRME"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1945210906016665984) 2025-07-15 19:56:34 UTC 13.6K followers, 3828 engagements "@robdubparker Very nice and two big data readouts November"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1948182088324153424) 2025-07-24 00:42:59 UTC 13.6K followers, XX engagements "Why Gene Editing is Finally Making a Move 🚀 X $LLY buyout of $VERV X David Liu buying $PRME shares X $XX million insider $CRSP buy X FDA sounding BULLISH on cures X Interest rate cuts coming 🤔 X ALL got way too cheap X $NTLA updated HAE Ph. X data X $PRME CGD data X $BEAM SCD/AATD data 🔟 Shorts got too comfortable"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1948354444329922569) 2025-07-24 12:07:52 UTC 13.6K followers, 9066 engagements "Congrats to $PRME on cracking $X 💪 Things in gene editing land are really heating up 🔥"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1947296650239631618) 2025-07-21 14:04:35 UTC 13.6K followers, 7078 engagements "@ShortsellerST @BiotechAnalysst But that is their new one. I assume that isnt being used in current drugs"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1946189055076532720) 2025-07-18 12:43:23 UTC 13.6K followers, XXX engagements "Living in a ghost town Also found out Mr. Beast gets his cacao from this remote area of Peru for his chocolate bars 🤯 Yes I bought some chocolate 🍫"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1944826648378912771) 2025-07-14 18:29:40 UTC 13.6K followers, 2451 engagements "Common questions by @PersimmonTI My reply: X Hemophilia A ($BMRN's Roctavian) Initial FVIII levels look good but rapid decline over time is well documented. Pivotal trial showed median FVIII expression dropped from XX IU/dL at year X to XX IU/dL by year X and the trend continues downward. Many patients require re-initiation of prophylaxis after a few years. Durability concerns are a major reason for slow uptake post-approval. X NTLA-2002 is gene knockout via CRISPR-Cas9 not viral vector-based gene addition. That means no episomal DNA no reliance on hepatocyte turnover and theoretically"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1934626375131967717) 2025-06-16 14:57:26 UTC 13.6K followers, 1564 engagements "@robdubparker Phase X results were never this year. But X big data readouts around early November or sooner. First phase X data in early part of next year"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1947343854727766080) 2025-07-21 17:12:09 UTC 13.6K followers, XXX engagements "We will all look back and laugh at the bears who said no one will want a one-time 2-4 hour outpatient CURE. $NTLA Insurance coverage and long term safety are all that remains as potential roadblocks. And with new FDA push for one-time cures things are looking VERY positive"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1935838370871337466) 2025-06-19 23:13:28 UTC 13.6K followers, 4677 engagements "@Gabrielmendesnu Yep been a surprise to me after verve buyout Im shocked"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1947761570295042418) 2025-07-22 20:52:00 UTC 13.6K followers, XXX engagements "Really healthy to see $NTLA +5.8% $CRSP +4.4% $BEAM +4.0% Despite $PRME taking a breather. Sometimes an exec leaving weighs the sector down so this is good for all of these companies"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1945497178249609345) 2025-07-16 14:54:07 UTC 13.6K followers, 2665 engagements "Interest in genome editing is currently 4x what it was at various points over the last X years. Often a leading indicator of stock performance CRISPR $NTLA $PRME $BEAM $CRSP"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1940044554335322329) 2025-07-01 13:47:20 UTC 13.6K followers, 5467 engagements "@LTbioinvestor Those last X run a lot and I would consider a trim for some $BEAM. Feel $NTLA and $BEAM are best values here"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1948393773567783418) 2025-07-24 14:44:09 UTC 13.6K followers, XXX engagements "@msaporto @hiteshkar @ZaStocks @pennycheck Needs $NTLA $BEAM $PRME $CRSP"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1947414429349646692) 2025-07-21 21:52:35 UTC 13.6K followers, XXX engagements "Big news for those watching in vivo CAR T 👀 $BEAM Orbital and Beam have a partnership that should allow Beam to use this technology"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1947647899023622368) 2025-07-22 13:20:19 UTC 13.6K followers, 6122 engagements "WOW 😮 $CRSP insider bought $XX million worth of stock. That is huge and not just in biotech. The entire market rarely sees a buy that large"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1946178733980737735) 2025-07-18 12:02:23 UTC 13.6K followers, 36.1K engagements "According to Stocktwits: $CRSP Simeon George Net Worth The estimated net worth of Simeon George is at least $XXX Million dollars as of 2025-07-18. Simeon George is the Director of Principia Biopharma Inc and owns about 2982855 shares of Principia Biopharma Inc (PRNB) stock worth over $XXX Million. Simeon George is the Director of Turning Point Therapeutics Inc and owns about 2253660 shares of Turning Point Therapeutics Inc (TPTX) stock worth over $XXX Million. Simeon George is also the Director of CRISPR Therapeutics AG and owns about 2038763 shares of CRISPR Therapeutics AG (CRSP) stock"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1946186030840795343) 2025-07-18 12:31:22 UTC 13.6K followers, XXX engagements "@BK7959925597715 @jawnzilla @techstonx @freshjiva Targeted How Lol"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1948434769626189942) 2025-07-24 17:27:03 UTC 13.6K followers, XX engagements "@CrisprGlenn X. $NTLA X. $PRME and $BEAM X. $CRSP"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1946570190184943765) 2025-07-19 13:57:53 UTC 13.6K followers, XXX engagements "Okay I can get used to this $NTLA Remember: there is still a relatively good chance at a triple from these levels. And given extra time 6x or more"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1947297699436380431) 2025-07-21 14:08:45 UTC 13.6K followers, 6408 engagements "And this doesnt even have their cash cow Vyndamax/Vyndaqel (Tafamidis) which brought in $XXX BILLION in 2024 and will likely go generic within the next few years. $PFE $BBIO $ALNY $NTLA ATTR CM"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1945621728173928501) 2025-07-16 23:09:02 UTC 13.6K followers, 3179 engagements "@Carey72290517 I fully expect transient liver elevations so that would be dumb if its transient lol"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1948435790783987714) 2025-07-24 17:31:07 UTC 13.6K followers, XXX engagements "OH SNAP 🤯 $CRSP and $XX million insider buy equals SHORT SQUEEZE"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1946201669991108789) 2025-07-18 13:33:31 UTC 13.6K followers, 16.4K engagements "@Tiger_Strat Look at X year ago and $REGN was bigger haha big divergence recently. Also $BEAM has $PFE Definitely cant say successfully scaled based on sales so far"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1946321913741013273) 2025-07-18 21:31:19 UTC 13.6K followers, XX engagements "Flashback to X weeks ago when the $NTLA haters were out in full force Had people saying the company should shut down 😱 Yet stock has doubled since then. If you listened to these people you wouldve missed out on 100%+ in X weeks. All because of a transient liver elevation that was less severe than my mono kissing disease (I suffered liver damage/jaundice and this patient did not). Main part I wanted to add Comparing CRISPR Cas9 to AAV based gene therapies isnt smart. AAV-based Gene Therapies (e.g. Roctavian Zolgensma Hemgenix): Use viral vectors that persist in the nucleus. Even though they"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1948008562719883733) 2025-07-23 13:13:28 UTC 13.6K followers, 6509 engagements "@jawnzilla Yeah they definitely shook me out of prime with CEO gone no deal and CGD shelved all right before Liu went on buying spree out of nowhere"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1948355469103243644) 2025-07-24 12:11:57 UTC 13.6K followers, XXX engagements "@GoldfarbBill Definitely. It was around $XX I think before the HAE readout started the cascade 🤮"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1948032752768426461) 2025-07-23 14:49:35 UTC 13.6K followers, XXX engagements "@crisprspace No. I specifically told everyone to not do that. I never told people to go all in lol People have thanked me a lot the last few weeks for them making money on $PRME and $NTLA I havent been all in that long"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1945493921070469565) 2025-07-16 14:41:10 UTC 13.6K followers, XXX engagements "@goooogles234 Entire sector is moving hard. Multiple insider buys across sector and buyout of VERV. Huge short interest and the sector got way too cheap"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1947299695585272258) 2025-07-21 14:16:41 UTC 13.6K followers, XX engagements "$NTLA dropping X% because of $SRPT is a joke. I dont expect green every day but the market trades like a very low IQ individual. Check out my post from yesterday explaining the major differences"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1948418275169223034) 2025-07-24 16:21:31 UTC 13.6K followers, 4412 engagements "@freshjiva @debesh_man Doesnt seem they understand this name. They have got other names correct recently and got a XXX% return on a name today. But they hate the idea of gene editing at its core"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1948025588444274955) 2025-07-23 14:21:07 UTC 13.6K followers, XXX engagements "@crisprspace $XXXX to $XXXX 🟰 XXXX% drop $PRME $XXXXX to $XXXXX 🟰 XXXX% drop $NTLA So you are actually incorrect"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1947349109792239678) 2025-07-21 17:33:02 UTC 13.6K followers, XXX engagements "The ACAAI conference is later this year (November 6-10 in Orlando). This is the conference $NTLA released their original Ph. X HAE data last year (was October 24-28). The AHA conference was November 16-18 last year. This year it will be November 8-10 in New Orleans. Seems like a lot of fire power to release all at once. If so youd expect HAE data on November 6-7 and ATTR on 8-10. But to spread out the catalysts Intellia might try to find something a bit earlier for HAE"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1947261835586961910) 2025-07-21 11:46:14 UTC 13.6K followers, 2044 engagements "@Rogue_Wolf61 Would love that because $NTLA would likely moon as the next potential 2-3 FDA approvals"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1946216631031734709) 2025-07-18 14:32:58 UTC 13.6K followers, XXX engagements "$PRME CSO is gone BUT $20+ million from Cystic Fibrosis foundation Definitely helps cushion the blow"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1945477515159720202) 2025-07-16 13:35:59 UTC 13.6K followers, 2394 engagements "@reindste @freshjiva Why couldnt it happen Tons of money gets traded on these each day"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1946239573459128396) 2025-07-18 16:04:08 UTC 13.6K followers, XX engagements "@FidelisAurelius @RNAiAnalyst @john_hersc79276 @adamfeuerstein Adam F has already gone after $NTLA multiple times so its not hard to believe at all"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1948452003992261079) 2025-07-24 18:35:32 UTC 13.6K followers, XXX engagements "Missed these updates from June 12th and the 18th $NTLA went from XXX to XXX sites in CM and from X to XX in PN. XXX enrolling now in CM which means they should be able to enroll 50+ per month if they keep their current rate. On pace to shatter the 550+ guidance by year end. In May they had XXX already enrolled. So XXX by year end is possible yet I expect December to be slow with the holidays. Remember PN only needs XX total patients. My hunch is they will try to have XX sites for X patients on average per"  [@GeneInvesting](/creator/x/GeneInvesting) on [X](/post/tweet/1939707527375000037) 2025-06-30 15:28:07 UTC 13.6K followers, 2008 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@GeneInvesting Gene Investing w/Anthony 🧬
Gene Investing w/Anthony 🧬 posts on X about $ntla, $crsp, $prme, $beam the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXXX engagements in the last XX hours.
Engagements: XXXXXX #
- X Week XXXXXX +104%
- X Month XXXXXXX -XX%
- X Months XXXXXXXXX -XXXX%
- X Year XXXXXXXXX -XXXX%
Mentions: XX #
- X Week XX +6.50%
- X Month XXX -XX%
- X Months XXXXX -XX%
- X Year XXXXX +32%
Followers: XXXXXX #
- X Week XXXXXX +0.75%
- X Month XXXXXX +2.20%
- X Months XXXXXX +19%
- X Year XXXXXX +34%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence finance XXXXX% cryptocurrencies #3332 stocks XXXX% technology brands XXXX% countries XXXX%
Social topic influence $ntla #1, $crsp #1, $prme #1, $beam #2, hae #26, insider 2.88%, vivo 2.88%, money 2.88%, $srpt 1.92%, $bbio XXXX%
Top accounts mentioned or mentioned by @crisprspace @rnaianalyst @jawnzilla @techstonx @hassanaesthetic @carey72290517 @yaireinhorn @masterlongevity @robdubparker @jessiechimni @steve2bacon @freshjiva @lovebostrom @biotech2k1 @anthonystaj @rolandoamoreno @crisprglenn @bk7959925597715 @vega_n1 @sguiderna
Top assets mentioned Intellia Therapeutics, Inc (NTLA) CRISPR Therapeutics AG (CRSP) BEAM (BEAM) Sarepta Therapeutics, Inc. (SRPT) BridgeBio Pharma, Inc. Common Stock (BBIO) Pfizer, Inc. (PFE) Muhdo Hub (DNA) GammaSwap (GS) Goldman Sachs (GS) Eli Lilly and Company (LLY) Bitcoin Incognito (XBI) Alnylam Pharmaceuticals, Inc. (ALNY) Viking Therapeutics, Inc (VKTX) TG Therapeutics, Inc. (TGTX) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Regeneron Pharmaceuticals Inc (REGN)
Top Social Posts #
Top posts by engagements in the last XX hours
"What a strong close for $NTLA 💪💪💪 +6.81% Also notable: $DNA +17.93% $CRBU +14.49% $ARKG +3.06% $BEAM +2.43% $CRSP and $PRME needed a breather after big runs"
@GeneInvesting on X 2025-07-22 20:04:30 UTC 13.6K followers, 4073 engagements
"@john_hersc79276 Because AAV based gene therapy and LNP based CRISPR are two very different animals" @GeneInvesting on X 2025-07-24 16:25:59 UTC 13.6K followers, XXX engagements
"I really want to bet someone that this guy is short some biotechs No bull could ever be this consistently negative EVERY SINGLE WEEK 🤦🏻♂ Look at his page a dozen or more $SRPT posts today and I dont see one mention of the $XX million insider buy at $CRSP 👀" @GeneInvesting on X 2025-07-18 19:27:13 UTC 13.6K followers, 5903 engagements
"Likely the biggest asshole on here. When $PRME was struggling I was comforting him and convincing him to believe in it. He apologized to me for being an asshole a few months ago because he was annoyed at how horrible $PRME and $NTLA were doing. Now he cant stomach X bad days in PRME without reverting to a giant asshole. You try to forgive people but they show their true colors when things go badly for them. Very odd hes not in a better mood considering how well Prime has done recently. Sorry that Prime was only my second favorite stock in the entire market. Ill try to do better next time 😂" @GeneInvesting on X 2025-07-16 15:19:47 UTC 13.6K followers, 10.8K engagements
"How can anyone trust Goldman Sachs X months ago they downgraded $NTLA from NEUTRAL to SELL with PT of $X. Now with the stock at $XX they put a SPOTLIGHT on only X stocks and Intellia is one of them. I havent seen them adjust their PT but really funny if they have a SELL rating with $X PT and pick it as their top X stocks at $XX. 🤣 Goldman identified three stocks that align with its broader market thesis and are poised to outperform in the second half of 2025: Kohls Intellia Therapeutics and Gogo Inc" @GeneInvesting on X 2025-07-18 21:05:06 UTC 13.6K followers, 4248 engagements
"$PRME $NTLA $BEAM $CRSP I begged for this for the last 1-2 years and they delivered. Itll be sparingly used at first but my hope is that it can help speed up follow up programs. Ex) HAE helping ATTR PN or PN helping CM. Definitely a slam dunk for CGD if government also reinstates rare disease voucher to help program make economic sense" @GeneInvesting on X 2025-07-22 17:38:51 UTC 13.6K followers, 4352 engagements
"@mathcoredad But my point is he uses it to try to be negative about all companies lol And he never reports the positive like $CRSP +18% on $XX million insider buy" @GeneInvesting on X 2025-07-19 13:16:10 UTC 13.6K followers, XXX engagements
"@RNAiAnalyst Ill take it. But I need to read up on this person" @GeneInvesting on X 2025-07-21 13:19:55 UTC 13.6K followers, XXX engagements
"Going to be fascinating to see what happens with $PRME the next X years. Very surprised no in vivo deals yet. Need rare disease voucher and/or partner for CGD. And will be very interesting what final arbitration result will be with $BEAM regarding AATD. Really bad job by the companies that their initial wording left the need for arbitration. This shouldve been written clearly in the forming documents of Prime" @GeneInvesting on X 2025-07-17 20:29:52 UTC 13.6K followers, 4114 engagements
"@RNAiAnalyst All time favorite Adam F moment was on $NTLA liver tox he posted about it literally a minute or two after filing and said oh is this new Like he didnt know 😂 And he never reports on the good news because that doesnt sell subscriptions I guess" @GeneInvesting on X 2025-07-19 14:43:04 UTC 13.6K followers, 2058 engagements
"This is proof as to why every biotech should have at least one person who is a billionaire or mega wealthy 😂 $CRSP The board members must love this guy" @GeneInvesting on X 2025-07-18 13:47:52 UTC 13.6K followers, 6743 engagements
"$BBIO has turned European Attruby rights into $XXX million in upfront cash (if we count near term $75m). Remarkable considering generic Tafamidis will cause significant pricing pressure within the next few years. Generic taf is a huge reason that $NTLA combo therapy results are SO important. If Intellia shows significant combo benefits itll make a strong case for combo therapy and put less pricing pressure on Intellia. Also Vutrisiran kept price its same for CM (and PN) which helps Intellia. Ive calculated my expectations for Intellias combo therapy and I think it could be significant. Many" @GeneInvesting on X 2025-07-01 17:49:57 UTC 13.6K followers, 4739 engagements
"Biggest Pros/Cons for the X Leading Gene Editing Companies $CRSP Pros: huge cash pile and pipeline Cons: slow Casgevy (40% ownership) ramp could weigh on stock a lot riding on ex vivo programs which are notoriously lower PoS $BEAM Pros: base editing king solid cash SCD (100%) franchise and AATD (100%) Cons: arbitration with PRME over AATD SCD is a slow commercial process $NTLA Pros: HAE (100%) and ATTR PN/CM (75%) Cons: no pipeline outside of three Ph. X trials needs more cash $PRME Pros: Prime editing king great tech Cons: very little cash so expect significant dilution. Outside of currently" @GeneInvesting on X 2025-07-11 14:27:34 UTC 13.6K followers, 9641 engagements
"I like how $NTLA is holding up today compared to $CRSP $BEAM and $PRME" @GeneInvesting on X 2025-07-15 19:56:34 UTC 13.6K followers, 3828 engagements
"@robdubparker Very nice and two big data readouts November" @GeneInvesting on X 2025-07-24 00:42:59 UTC 13.6K followers, XX engagements
"Why Gene Editing is Finally Making a Move 🚀 X $LLY buyout of $VERV X David Liu buying $PRME shares X $XX million insider $CRSP buy X FDA sounding BULLISH on cures X Interest rate cuts coming 🤔 X ALL got way too cheap X $NTLA updated HAE Ph. X data X $PRME CGD data X $BEAM SCD/AATD data 🔟 Shorts got too comfortable" @GeneInvesting on X 2025-07-24 12:07:52 UTC 13.6K followers, 9066 engagements
"Congrats to $PRME on cracking $X 💪 Things in gene editing land are really heating up 🔥" @GeneInvesting on X 2025-07-21 14:04:35 UTC 13.6K followers, 7078 engagements
"@ShortsellerST @BiotechAnalysst But that is their new one. I assume that isnt being used in current drugs" @GeneInvesting on X 2025-07-18 12:43:23 UTC 13.6K followers, XXX engagements
"Living in a ghost town Also found out Mr. Beast gets his cacao from this remote area of Peru for his chocolate bars 🤯 Yes I bought some chocolate 🍫" @GeneInvesting on X 2025-07-14 18:29:40 UTC 13.6K followers, 2451 engagements
"Common questions by @PersimmonTI My reply: X Hemophilia A ($BMRN's Roctavian) Initial FVIII levels look good but rapid decline over time is well documented. Pivotal trial showed median FVIII expression dropped from XX IU/dL at year X to XX IU/dL by year X and the trend continues downward. Many patients require re-initiation of prophylaxis after a few years. Durability concerns are a major reason for slow uptake post-approval. X NTLA-2002 is gene knockout via CRISPR-Cas9 not viral vector-based gene addition. That means no episomal DNA no reliance on hepatocyte turnover and theoretically" @GeneInvesting on X 2025-06-16 14:57:26 UTC 13.6K followers, 1564 engagements
"@robdubparker Phase X results were never this year. But X big data readouts around early November or sooner. First phase X data in early part of next year" @GeneInvesting on X 2025-07-21 17:12:09 UTC 13.6K followers, XXX engagements
"We will all look back and laugh at the bears who said no one will want a one-time 2-4 hour outpatient CURE. $NTLA Insurance coverage and long term safety are all that remains as potential roadblocks. And with new FDA push for one-time cures things are looking VERY positive" @GeneInvesting on X 2025-06-19 23:13:28 UTC 13.6K followers, 4677 engagements
"@Gabrielmendesnu Yep been a surprise to me after verve buyout Im shocked" @GeneInvesting on X 2025-07-22 20:52:00 UTC 13.6K followers, XXX engagements
"Really healthy to see $NTLA +5.8% $CRSP +4.4% $BEAM +4.0% Despite $PRME taking a breather. Sometimes an exec leaving weighs the sector down so this is good for all of these companies" @GeneInvesting on X 2025-07-16 14:54:07 UTC 13.6K followers, 2665 engagements
"Interest in genome editing is currently 4x what it was at various points over the last X years. Often a leading indicator of stock performance CRISPR $NTLA $PRME $BEAM $CRSP" @GeneInvesting on X 2025-07-01 13:47:20 UTC 13.6K followers, 5467 engagements
"@LTbioinvestor Those last X run a lot and I would consider a trim for some $BEAM. Feel $NTLA and $BEAM are best values here" @GeneInvesting on X 2025-07-24 14:44:09 UTC 13.6K followers, XXX engagements
"@msaporto @hiteshkar @ZaStocks @pennycheck Needs $NTLA $BEAM $PRME $CRSP" @GeneInvesting on X 2025-07-21 21:52:35 UTC 13.6K followers, XXX engagements
"Big news for those watching in vivo CAR T 👀 $BEAM Orbital and Beam have a partnership that should allow Beam to use this technology" @GeneInvesting on X 2025-07-22 13:20:19 UTC 13.6K followers, 6122 engagements
"WOW 😮 $CRSP insider bought $XX million worth of stock. That is huge and not just in biotech. The entire market rarely sees a buy that large" @GeneInvesting on X 2025-07-18 12:02:23 UTC 13.6K followers, 36.1K engagements
"According to Stocktwits: $CRSP Simeon George Net Worth The estimated net worth of Simeon George is at least $XXX Million dollars as of 2025-07-18. Simeon George is the Director of Principia Biopharma Inc and owns about 2982855 shares of Principia Biopharma Inc (PRNB) stock worth over $XXX Million. Simeon George is the Director of Turning Point Therapeutics Inc and owns about 2253660 shares of Turning Point Therapeutics Inc (TPTX) stock worth over $XXX Million. Simeon George is also the Director of CRISPR Therapeutics AG and owns about 2038763 shares of CRISPR Therapeutics AG (CRSP) stock" @GeneInvesting on X 2025-07-18 12:31:22 UTC 13.6K followers, XXX engagements
"@BK7959925597715 @jawnzilla @techstonx @freshjiva Targeted How Lol" @GeneInvesting on X 2025-07-24 17:27:03 UTC 13.6K followers, XX engagements
"@CrisprGlenn X. $NTLA X. $PRME and $BEAM X. $CRSP" @GeneInvesting on X 2025-07-19 13:57:53 UTC 13.6K followers, XXX engagements
"Okay I can get used to this $NTLA Remember: there is still a relatively good chance at a triple from these levels. And given extra time 6x or more" @GeneInvesting on X 2025-07-21 14:08:45 UTC 13.6K followers, 6408 engagements
"And this doesnt even have their cash cow Vyndamax/Vyndaqel (Tafamidis) which brought in $XXX BILLION in 2024 and will likely go generic within the next few years. $PFE $BBIO $ALNY $NTLA ATTR CM" @GeneInvesting on X 2025-07-16 23:09:02 UTC 13.6K followers, 3179 engagements
"@Carey72290517 I fully expect transient liver elevations so that would be dumb if its transient lol" @GeneInvesting on X 2025-07-24 17:31:07 UTC 13.6K followers, XXX engagements
"OH SNAP 🤯 $CRSP and $XX million insider buy equals SHORT SQUEEZE" @GeneInvesting on X 2025-07-18 13:33:31 UTC 13.6K followers, 16.4K engagements
"@Tiger_Strat Look at X year ago and $REGN was bigger haha big divergence recently. Also $BEAM has $PFE Definitely cant say successfully scaled based on sales so far" @GeneInvesting on X 2025-07-18 21:31:19 UTC 13.6K followers, XX engagements
"Flashback to X weeks ago when the $NTLA haters were out in full force Had people saying the company should shut down 😱 Yet stock has doubled since then. If you listened to these people you wouldve missed out on 100%+ in X weeks. All because of a transient liver elevation that was less severe than my mono kissing disease (I suffered liver damage/jaundice and this patient did not). Main part I wanted to add Comparing CRISPR Cas9 to AAV based gene therapies isnt smart. AAV-based Gene Therapies (e.g. Roctavian Zolgensma Hemgenix): Use viral vectors that persist in the nucleus. Even though they" @GeneInvesting on X 2025-07-23 13:13:28 UTC 13.6K followers, 6509 engagements
"@jawnzilla Yeah they definitely shook me out of prime with CEO gone no deal and CGD shelved all right before Liu went on buying spree out of nowhere" @GeneInvesting on X 2025-07-24 12:11:57 UTC 13.6K followers, XXX engagements
"@GoldfarbBill Definitely. It was around $XX I think before the HAE readout started the cascade 🤮" @GeneInvesting on X 2025-07-23 14:49:35 UTC 13.6K followers, XXX engagements
"@crisprspace No. I specifically told everyone to not do that. I never told people to go all in lol People have thanked me a lot the last few weeks for them making money on $PRME and $NTLA I havent been all in that long" @GeneInvesting on X 2025-07-16 14:41:10 UTC 13.6K followers, XXX engagements
"@goooogles234 Entire sector is moving hard. Multiple insider buys across sector and buyout of VERV. Huge short interest and the sector got way too cheap" @GeneInvesting on X 2025-07-21 14:16:41 UTC 13.6K followers, XX engagements
"$NTLA dropping X% because of $SRPT is a joke. I dont expect green every day but the market trades like a very low IQ individual. Check out my post from yesterday explaining the major differences" @GeneInvesting on X 2025-07-24 16:21:31 UTC 13.6K followers, 4412 engagements
"@freshjiva @debesh_man Doesnt seem they understand this name. They have got other names correct recently and got a XXX% return on a name today. But they hate the idea of gene editing at its core" @GeneInvesting on X 2025-07-23 14:21:07 UTC 13.6K followers, XXX engagements
"@crisprspace $XXXX to $XXXX 🟰 XXXX% drop $PRME $XXXXX to $XXXXX 🟰 XXXX% drop $NTLA So you are actually incorrect" @GeneInvesting on X 2025-07-21 17:33:02 UTC 13.6K followers, XXX engagements
"The ACAAI conference is later this year (November 6-10 in Orlando). This is the conference $NTLA released their original Ph. X HAE data last year (was October 24-28). The AHA conference was November 16-18 last year. This year it will be November 8-10 in New Orleans. Seems like a lot of fire power to release all at once. If so youd expect HAE data on November 6-7 and ATTR on 8-10. But to spread out the catalysts Intellia might try to find something a bit earlier for HAE" @GeneInvesting on X 2025-07-21 11:46:14 UTC 13.6K followers, 2044 engagements
"@Rogue_Wolf61 Would love that because $NTLA would likely moon as the next potential 2-3 FDA approvals" @GeneInvesting on X 2025-07-18 14:32:58 UTC 13.6K followers, XXX engagements
"$PRME CSO is gone BUT $20+ million from Cystic Fibrosis foundation Definitely helps cushion the blow" @GeneInvesting on X 2025-07-16 13:35:59 UTC 13.6K followers, 2394 engagements
"@reindste @freshjiva Why couldnt it happen Tons of money gets traded on these each day" @GeneInvesting on X 2025-07-18 16:04:08 UTC 13.6K followers, XX engagements
"@FidelisAurelius @RNAiAnalyst @john_hersc79276 @adamfeuerstein Adam F has already gone after $NTLA multiple times so its not hard to believe at all" @GeneInvesting on X 2025-07-24 18:35:32 UTC 13.6K followers, XXX engagements
"Missed these updates from June 12th and the 18th $NTLA went from XXX to XXX sites in CM and from X to XX in PN. XXX enrolling now in CM which means they should be able to enroll 50+ per month if they keep their current rate. On pace to shatter the 550+ guidance by year end. In May they had XXX already enrolled. So XXX by year end is possible yet I expect December to be slow with the holidays. Remember PN only needs XX total patients. My hunch is they will try to have XX sites for X patients on average per" @GeneInvesting on X 2025-06-30 15:28:07 UTC 13.6K followers, 2008 engagements